Health Secretary Robert F. Kennedy Jr. is taking bold steps to remove industry influence from federal vaccine policy, challenging what he sees as Big Pharma’s grip over public health decisions. According to sources, Kennedy plans to overhaul advisory panels, including the CDC’s powerful Advisory Committee on Immunization Practices (ACIP), which recommends vaccines. His goal is to eliminate conflicts of interest and restore integrity to health policy.

Kennedy has long criticized the cozy relationship between government regulators and pharmaceutical giants, arguing that vaccine advisory committees are stacked with individuals with financial ties to the industry. As head of HHS, he is moving to ensure that public health decisions prioritize people over profits.

His scrutiny extends beyond ACIP to FDA advisory panels, which play a key role in approving vaccines. While he has yet to finalize removals or replacements, the mere prospect has alarmed entrenched health bureaucrats who have long operated with little accountability.

Kennedy’s critics claim his efforts could erode public confidence in vaccines, but he maintains that transparency will strengthen trust, not weaken it. He argues that by eliminating conflicts of interest, Americans will finally have a vaccine policy based on science and public welfare – not pharmaceutical profit margins.

For decades, drugmakers have dictated the nation’s immunization agenda. RFK Jr. is determined to change that.